Segment Information (Tables)

6 Months Ended

Mar. 31, 2013

Financial Information for Business Segments

Financial information for the Company’s business segments is as follows (in thousands):

	Brooks Product Solutions			Brooks Global Services		Brooks Life Science Systems			Total
Three months ended March 31, 2013
Revenues
Product	$	85,404		$	3,731	$	6,358		$	95,493
Services	—			18,369		2,757			21,126
	$	85,404		$	22,100	$	9,115		$	116,619
Gross profit	$	27,685		$	6,516	$	2,411		$	36,612
Segment operating income (loss)	$	3,523		$	1,956	$	(3,875	)	$	1,604
Three months ended March 31, 2012
Revenues
Product	$	103,456		$	3,015	$	11,150		$	117,621
Services	—			18,220		3,496			21,716
	$	103,456		$	21,235	$	14,646		$	139,337
Gross profit	$	35,885		$	6,591	$	5,806		$	48,282
Segment operating income (loss)	$	7,597		$	2,195	$	(105	)	$	9,687
Six months ended March 31, 2013
Revenues
Product	$	148,126		$	7,236	$	17,454		$	172,816
Services	—			36,029		5,799			41,828
	$	148,126		$	43,265	$	23,253		$	214,644
Gross profit	$	45,439		$	11,626	$	8,705		$	65,770
Segment operating income (loss)	$	(2,911	)	$	2,547	$	(3,897	)	$	(4,261	)
Six months ended March 31, 2012
Revenues
Product	$	188,750		$	5,392	$	20,577		$	214,719
Services	—			37,937		6,909			44,846
	$	188,750		$	43,329	$	27,486		$	259,565
Gross profit	$	64,286		$	13,727	$	10,626		$	88,639
Segment operating income (loss)	$	8,682		$	5,144	$	(738	)	$	13,088
Assets
March 31, 2013	$	251,174		$	63,799	$	100,102		$	415,075
September 30, 2012	$	218,799		$	56,120	$	107,530		$	382,449

Reconciliation of Reportable Segment Operating Income (Loss) to Corresponding Consolidated Amounts

A reconciliation of the Company’s reportable segment operating income (loss) to the corresponding consolidated amounts for the three and six month periods ended March 31, 2013 and 2012 is as follows (in thousands):

	Three months ended March 31,						Six months ended March 31,
	2013			2012			2013			2012
Segment operating income (loss)	$	1,604		$	9,687		$	(4,261	)	$	13,088
Other unallocated corporate expenses	394			(2,934		)	1,284			(2,416		)
Amortization of acquired intangible assets	1,413			1,138			2,965			2,355
Restructuring and other charges	769			42			5,526			245
In-process research and development	—			3,026			—			3,026
Total operating income (loss)	$	(972	)	$	8,415		$	(14,036	)	$	9,878

Reconciliation of Reportable Segment Assets to Corresponding Consolidated Amounts

A reconciliation of the Company’s reportable segment assets to the corresponding consolidated amounts as of March 31, 2013 and September 30, 2012 is as follows (in thousands):

	March 31, 2013		September 30, 2012
Segment assets	$	415,075	$	382,449
Investments in cash, cash equivalents, restricted cash and marketable securities	145,574		200,994
Deferred tax assets	118,011		120,157
Investments in joint ventures	28,425		31,428
Other unallocated corporate net assets	14,677		6,932
Total assets	$	721,762	$	741,960